RMaaS

Risk Management as a Service


Keep your projects on track by knowing and limiting the risks

Outsource your
Risk Management

And reduce costly delays


The central aim of risk management is to reduce the likelihood and impact of risks.


Organisations require a thorough risk management framework, policies and engagement at every level of the business to gain oversight and control.


There are a number of different risk management frameworks that can be used, such as ISO 31000 and COSO ERM. It is very important to choose the right framework for your business as you scale.


We can help with all aspects of your risk management system if you lack the relevant in-house expertise.

Our Approach


  1. Identify risks: we conduct a detailed risk assessment, which involves identifying the potential sources of risk, the likelihood of each risk occurring, and the impact of each risk if it does occur

  2. Assess risks: we predict the likelihood of each risk
    occurring and the scale of each risk if it does occur

  3. Prioritise risks: we prioritise, so you can focus on the most severe risks. We use a detailed risk matrix, which assigns a score to each risk based on its likelihood and impact

  4. Risk treatment: this is accomplished by mitigating risks, transferring risks to another party, or accepting risks

  5. Monitor risks: we can monitor or set up a system to monitor risks on an ongoing basis to ensure that they are being managed effectively


Benefits of our model


Reduced Risk

Helps to reduce the likelihood and impact of risks. This will protect you from financial loss, reputational damage, and other negative consequences

Improved Decision-Making

Helps your organisation make better decisions by providing you with a detailed, up-to-date risk matrix

Increased Efficiency

Improves your efficiency by identifying and eliminating unnecessary risks

Increased Compliance

Makes it easier to comply with industry regulations by identifying and managing risks that could lead to non-compliance

Stakeholder Confidence

Increases stakeholder confidence by demonstrating that your organisation is taking steps to manage all risks

Ready to talk?

Our Risk Management experts have years of experience and use an iterative, waterfall methodology to significantly improve success rates. Get in touch today to discuss how we can help.

BOOK A CONSULTATION

"Cambridge MC helped the University of Bristol complete a multi-million modern network design & procurement, ensuring that University of Bristol remains the university of choice for student, academics and partners in a globally competitive market."


—University of Bristol Case Study

Industry insights


16 November 2026
10 November 2026 – London – IThe search is on for the next generation of game-changing founders, pioneering companies and breakthrough innovations as #21toWatch opens the nominations window for its prestigious 2027 awards. Run by Cambridge Management Consulting, #21toWatch has a proven track record of spotlighting emerging talent and technologies from Cambridge and across the East of England - ventures with the potential to translate ambitious ideas into meaningful commercial and societal impact. Submissions typically span all areas of cutting-edge emerging innovation including artificial intelligence, deep tech, medtech, life sciences, biotechnology and climate technology. Some of the exciting entries already received for 2027 are as follows: In the ‘People’ category, biochemist, Dr Irina Gostimskaya, co-founder and CEO of Cambridge Molecular Computers, is a leading authority on reading, writing, and editing DNA. With her team at Cambridge Molecular Computers, she is building an alternative computing platform beyond silicon, using the programmability of DNA to solve previously intractable problems. Trading space for time, a DNA computer enables a desktop machine to outperform the world’s current fastest supercomputer, while consuming only a fraction of the energy. In the ‘Company’ category, pioneering femtech startup, Avline Health is building a pioneering intelligent clinical decision-support platform that combines individual patient risk assessment with evidence-informed treatment recommendations for genitourinary syndrome of menopause (GSM) after breast cancer. Combining vaginal microbiome sequencing, treatment history and longitudinal health data, Avline Health aims to provide clinicians with an objective severity score and a contraindication-aware treatment match, instead of a guess. CEO and co-founder, Dr. Josiane Chuisseu told us: “Vaginal microbiome testing does already exist - but nobody's built it for oncology before, and it’s very much needed. Up to 70% of breast cancer survivors develop genitourinary syndrome of menopause (GSM), a chronic and progressive condition caused by a drop in oestrogen levels - but it's chronically underdiagnosed because assessment still relies on subjective exams, and undertreated because clinicians are often too cautious to prescribe hormone therapy in cancer patients even when it's now shown to be safe. “As a result, two-thirds of women get the wrong diagnosis, and the treatments they do get are only effective less than 20% of the time." Meanwhile, in the ‘Things’ category, Metcycle is developing a scalable, energy-efficient technology to transform lithium-ion battery black mass into high-value critical materials. By addressing the industry’s key separation bottleneck, Metcycle aims to reduce reliance on energy-intensive and chemical-heavy recycling routes, enabling more economical recovery of battery metals while strengthening Europe’s domestic supply of critical raw materials. The 2027 #21toWatch campaign follows a year of incredible innovation across the region, with last year’s winning cohort continuing to make significant progress across investment, commercialisation and innovation: 2026 #21toWatch winner, Memorify has launched its Yoree memory platform following an oversubscribed £420k pre-seed investment round and a waitlist of more than 5,000 prospective users. Elsewhere, fellow winner, Loop52 has been selected for a share of a £2.7m Government-backed automotive innovation funding programme while another 2026 winner, Myonerv has won a £100k Innovate UK grant to advance clinical testing of its wearable stroke-rehabilitation technology, and 2026 winner, Cyclana Bio, which aims to find a cure for endometriosis, has secured approval for a 500-patient clinical study. Tim Passingham, founder and executive chairman of Cambridge Management Consulting, said: “Together, these achievements demonstrate the breadth of progress being made by the #21toWatch community, from attracting investment and bringing products to market to advancing clinical research and developing technologies with significant industrial potential. “#21toWatch is all about the importance of identifying promising innovators early and helping them gain the recognition and connections needed to scale. However, we are delighted that the impact of #21toWatch extends well beyond the awards.” Collectively, past winners have now raised more than £1billion, underlining the scale of the technical ambition among the ventures, and the importance of bringing such innovators to the attention of investors, customers and the wider business community. The #21toWatch shortlist – judged by a panel of independent judges - will be announced on 3 February 2027, with the final Top21, selected across three categories: People, Companies and Things, unveiled at an awards ceremony at Pembroke College, Cambridge, on 11 March 2027. Founders, companies and innovators can submit their own nominations through the #21toWatch website at https://www.21towatch.com/. Deadline for entries is 8 January 2027. Nominations are also invited from investors, universities and others across the innovation ecosystem. The judging process considers innovation, the challenge being addressed, influence, viability and memorability. Marks & Clerk returns as a premium sponsor of the 2027 #21toWatch campaign. Matthew Pinney, Office Managing Partner, Marks & Clerk Cambridge, said: “Cambridge has an extraordinary depth of entrepreneurial talent, and #21toWatch provides a valuable platform for recognising those innovators turning ambitious ideas into businesses with real commercial potential. We look forward to meeting this year’s cohort, learning more about their ambitions, and helping them protect and maximise the value of their innovations through intellectual property as they contribute to the region’s continuing success as a centre for innovation.” Further sponsors and the full judging panel will be announced shortly.
Big Ben and London cityscape at night – neon overlay
11 November 2026
Cambridge MC acquires Alpine Resourcing, a London-based public sector specialist, extending its reach across central and local government in the UK | READ PRESS RELEASE
A representation of agent boxes (prompts) linked into a workflow on a computer screen.
by Charlotte Patrick • 9 November 2026
RESEARCH & ANALYSIS | Cambridge AIQ assesses 13 vendors delivering agentic AI for service assurance, comparing four distinct strategies and the key factors operators must weigh | READ PREVIEW & PURCHASE REPORT
Audience at the recent launch event for the #21toWatch 2027 awards at the Glasshouse, Cambridge.
9 November 2026
A new monthly event series for scaleup founders, investors, and advisers at The Glasshouse, Cambridge. Starts 26 November with CMR Surgical’s Martin Frost CBE | READ FULL PRESS RELEASE
SHOW MORE
Front profile of Jason Jennings

Jason Jennings

Managing Partner - Project Management


Our Risk Management service is run by Jason Jennings


Jason is an advisor to numerous organisations and has extensive senior executive experience in the information and communications technology industry. He is the Managing Partner for Digital Transformation and lead for Cambridge MC’s Project Management as a Service capability.


Jason is a highly experienced CIO with strong commercial, business transformation and team building skills. He has a proven track record in delivering complex technology solutions for large international organisations across multiple territories. With demonstrable experience in delivering significant cost saving and improved technology-to-business alignment, Jason specialises in transformation, programme and project management, contract negotiation, outsourcing and interim management.

Get in touch with our Consultants today


We are a highly collaborative team of senior-level executive professionals able to adapt to any challenge, however niche & challenging.

+44 (0)1223 750335

info@cambridgemc.com

Contact Form - Technology Practice

Our team can be your team


Our team of experts have multiple decades  of experience across many different business environments and across various geographies.


We can build you a specialised team with the skillset and expertise required to meet the demands of your industry.


Our combination of expertise and an intelligent methodology is what realises tangible financial benefits for clients.

SPEAK TO THE TEAM

Our Project Management Experts